Pharmaceutical biotechnology in Poland: industry expected to boom in 2011
No significant development in biotechnology before 2011
In the last two years the Polish pharmaceutical biotechnology industry in Poland has seen a significant reduction in the annual rate of sales growth, according to the latest PMR Publications report “Biotechnological innovations in the pharmaceutical industry in Poland”. According to PMR Publications estimates, in 2008 the industry’s revenues suffered as a result of a deterioration in the performance of Bioton, the largest Polish biotech company. It was estimated that, in 2008, biotech companies in the Polish pharmaceutical industry achieved combined sales worth PLN 607m (€173m), around 2% less than the 2007 figure. Nevertheless, in future years, despite the uncongenial economic situation, the market will grow at several percent per year, and in 2011 sales should improve by almost 30% year on year. This will be a consequence of the development of innovative projects which are, today, at the inception or start-up stage and are not yet yielding a return.
EU funds growth of energy industry
As elsewhere in the world, access to high risk financing is crucial to the development of innovative technologies. The availability of EU funds in Poland has made it possible to support the development of investment firms interested in putting money into biotechnology industry ventures which carry some risk. The Innovative Economy Operational Programme is the most important of the accessible EU funds. In addition, as a result of the appropriate use of EU funds, it is, today, easier for companies active in Poland to fund investment in research into and the implementation of innovative technologies. In our opinion, despite the lamentable global economic situation, in the short term Poland has a chance to develop a real biotechnological industry.
According to the Ministry of Economic Affairs, between 2007 and 2013 companies and scientific institutions in the medical, pharmaceutical and biotechnological industries will, with the help of EU funds, implement projects worth around PLN 662m, or approximately €150m, in all (The Innovative Economy Operational Programme), of which PLN 120m (approximately €27m) will be allocated to projects associated with the medical equipment and technologies market and with dietary supplements . Meanwhile, the bulk of the remaining EU funds will be directly or indirectly associated with red biotechnology in Poland. This figure is not final, as many tenders have not yet been completed. In addition, more competitions are to be announced.
Increasing number of innovative projects
Although official statistics do not show an increase in the number of biotechnological companies in Poland, this has, in fact, grown in recent years. For example, in 2007 two biotechnological companies, Mabion and Selvita, were established, and one in 2008 – Celther.
The fact that Polish life sciences are just beginning to develop intensively is best illustrated by the number of new innovative ventures, particularly those in the biotechnology industry linked with the pharmaceutical industry. Significant innovative projects include those carried out by companies such as:
• Celther (stem cell therapy)
• Celon Pharma (siRNA-based therapy)
• Mabion (modified monoclonal antibody therapy)
• Euroimplant (tissue engineering and regenerative medicine)
• Biocontract (innovative vaccines for skin and kidney cancer).
With regard to the abovementioned fields, which are the focus of today’s efforts on the part of Polish firms, these will, in the future, undoubtedly provide a competitive edge for the Polish red biotechnology industry.
This press release is based on information contained in the latest PMR report entitled “Biotechnological innovations in the pharmaceutical industry in Poland 2009. Development forecasts for biotechnology sector for 2009-2011”.
For more information on the report please contact:
tel. /48/ 12 618 90 00
PMR Publications (www.pmrpublications.com) is a division of PMR, a company providing market information, advice and services to international businesses interested in Central and Eastern European countries and other emerging markets. PMR key areas of operation include market research (through PMR Research), consultancy (through PMR Consulting) and business publications (through PMR Publications). With over 13 years of experience, highly skilled international staff and coverage of over 20 countries, PMR is one of the largest companies of its type in the region.
ul. Supniewskiego 9, 31-527 Krakow, Poland
tel. /48/ 12 618 90 00, fax /48/ 12 618 90 08
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharmaceutical biotechnology in Poland: industry expected to boom in 2011 here
News-ID: 93419 • Views: 799
More Releases from PMR Publications
Russian retail market recovered after the economic slowdown
Retail markets in all Russian Federal Districts increased in 2010 by total $80bn In 2010, Russian retail market recovered after the economic slowdown observed in the previous year and increased by 12.6% to RUB 16.4tr ($541bn). However, the latest PMR report „Retail in Russia 2011 – Regional focus. Market analysis and development forecasts for 2011-2013” shows that particular regional retail markets still reveal differences in their development due to their unique
Construction output in Poland up by 10% in 2011
The forthcoming year 2011 can be a breakthrough year for the construction industry in terms of construction output. Provided that the winter weather conditions are relatively favourable, the 2011 average annual growth rate can be up to 10%, driven by large civil engineering projects and major improvement in the building construction sector. According to a report prepared by research company PMR, which is entitled "Construction sector in Poland, H2 2010 -
Russian construction industry recovers after the downturn
For the first time this decade, in 2009 the construction industry in Russia, which was severely affected by the global economic downturn, shrank in comparison with the preceding year. In the current year, a recovery has begun, prompted by the numerous projects supported or directly funded by the government. In the next few months, growth in the construction industry will be driven by the civil engineering and residential construction subdivisions
Retail market in Russia to grow by almost 10% in 2010
The growth rate of the Russian retail sector dropped severely last year due to worsening economic conditions, weakening purchasing power growth and the depreciating rouble. As a result, the retail market's value increased by only 5% in 2009 after several years of roughly 25% annual growth. Nevertheless, the situation has improved this year, and the retail market is expected to once again reach double-digit growth rates in subsequent years. According to
More Releases for Poland
MAUSER Poland Celebrates 5th Anniversary
Bruehl/Germany, June 27, 2017 MAUSER Group, a worldwide leading company in industrial packaging, celebrates the 5th anniversary of its factory in Gliwice, Poland. Ideally located in the industrial heartland of Upper Silesia, and operated by a strong local management team, the plant offers high-quality industrial packaging solutions and services. MAUSER Poland serves customers with a comprehensive product range of Composite Intermediate Bulk Containers (CIBCs) and plastic tight-head drums. In line with
Agrochemicals Market in Poland
ReportsWorldwide has announced the addition of a new report title Poland: Agrochemicals: Market Intelligence (2016-2021) to its growing collection of premium market research reports. The report “Poland: Agrochemicals: Market Intelligence (2016-2021)” provides market intelligence on the different market segments, based on type, active ingredient, formulation, crop, and pest. Market size and forecast (2016-2021) has been provided in terms of both, value (000 USD) and volume (000 KG) in the report. A
A+ ratings on Poland
Jelenia Gora/Poland, 20.09.2011 - In August 2011 two rating agencies i.e. Standard & Poor's and Moody's Investors Service affirmed their A+ rating on Poland with a stable outlook. Both agencies noted that the Polish economy is competitive and increasingly diversified. Moody's evaluated Poland as relatively well placed to withstand global turmoil with its relatively resilient economy. Both agencies stressed that the Polish economy continued to expand in 2009, in contrast
IT market in Poland
IT providers in Poland are starting the post-crisis period in actually quite good moods and are already beginning to predict what solutions will be most sought after by their customers during prosperity. However last year hardware distributors recorded significant reduction in the number of orders placed, especially by business customers, software and IT services providers performed far better. A majority of them had similar sales as in previous periods, while some
VoIP in Poland
At the end of 2008 the Polish VoIP telephony market was worth PLN 440m, with CaTV operators having generated the largest share of revenue in the segment. In recent years also fixed-line operators have included VoIP services into their offer. According to research and consulting company PMR Polish VoIP market continues to represent a small share of the fixed-line telecommunications market. In 2008 it accounted for approximately five percent of the
Private healthcare market in Poland
In 2008 the value of the private healthcare market in Poland amounted to PLN 26bn (€7.4bn), having risen by 13% on the 2007 figure. Due to the absence of the required legal changes and the economic crisis, the market will grow at a slower pace in the coming years, rising by 7-11% year on year, as disclosed in the latest PMR report entitled “Private healthcare market in Poland 2009. Development